These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 25055060

  • 21. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q, Wang XL, Liao ML, Hu J, Yang ZK, Ding FH, Zhang JS, Du R, Zhu TQ, Shen WF, Zhang RY.
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [Abstract] [Full Text] [Related]

  • 22. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW, Yang HB, Chen YH, Ma JY, Qian JY, Ge JB.
    BMC Cardiovasc Disord; 2017 Feb 27; 17(1):69. PubMed ID: 28241795
    [Abstract] [Full Text] [Related]

  • 23. Plaque Characterization to Inform the Prediction and Prevention of Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention: The CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow).
    Stone GW, Maehara A, Muller JE, Rizik DG, Shunk KA, Ben-Yehuda O, Genereux P, Dressler O, Parvataneni R, Madden S, Shah P, Brilakis ES, Kini AS, CANARY Investigators.
    JACC Cardiovasc Interv; 2015 Jun 27; 8(7):927-36. PubMed ID: 26003018
    [Abstract] [Full Text] [Related]

  • 24. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ, Herrmann J, Yün S, Lehmann N, Wang Z, Heusch G, Sack S, Erbel R, Levkau B.
    Eur Heart J; 2009 Aug 27; 30(15):1894-902. PubMed ID: 19474052
    [Abstract] [Full Text] [Related]

  • 25. Differential Rates and Clinical Significance of Periprocedural Myocardial Infarction After Stenting or Bypass Surgery for Multivessel Coronary Disease According to Various Definitions.
    Cho MS, Ahn JM, Lee CH, Kang DY, Lee JB, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ.
    JACC Cardiovasc Interv; 2017 Aug 14; 10(15):1498-1507. PubMed ID: 28797425
    [Abstract] [Full Text] [Related]

  • 26. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome.
    Gibson CM, Karmpaliotis D, Kosmidou I, Murphy SA, Kirtane AJ, Budiu D, Ray KK, Herrmann HC, Lakkis N, Kovach R, French W, Blankenship J, Lui HH, Palabrica T, Jennings LK, Cohen DJ, Morrow DA, TIMI Study Group.
    Am J Cardiol; 2006 May 15; 97(10):1473-7. PubMed ID: 16679086
    [Abstract] [Full Text] [Related]

  • 27. Impact of crossing technique on the incidence of periprocedural myocardial infarction during chronic total occlusion percutaneous coronary intervention.
    Stetler J, Karatasakis A, Christakopoulos GE, Tarar MN, Amsavelu S, Patel K, Rangan BV, Roesle M, Resendes E, Grodin J, Abdullah S, Banerjee S, Brilakis ES.
    Catheter Cardiovasc Interv; 2016 Jul 15; 88(1):1-6. PubMed ID: 27014962
    [Abstract] [Full Text] [Related]

  • 28. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX, Li XL, Zhang MZ, Wang XW, Guo YL, Zhu CG, Ren Y, Li S, Zhang Y, Liu G, Xu RX, Dong Q, Li JJ.
    Scand J Clin Lab Invest; 2015 Nov 15; 75(7):568-77. PubMed ID: 26203960
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M, Orliński L, Łobos M, Ciesielczyk M, Wlazeł RN, Paradowski MT.
    Pol Merkur Lekarski; 2010 Jun 15; 28(168):444-9. PubMed ID: 20642101
    [Abstract] [Full Text] [Related]

  • 30. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
    Zhou Y, Chen Z, Ma J, Chen A, Lu D, Wu Y, Ren D, Zhang C, Dai C, Zhang Y, Qian J, Ge J.
    J Cardiol; 2020 Sep 15; 76(3):309-316. PubMed ID: 32354492
    [Abstract] [Full Text] [Related]

  • 31. Relation of Neutrophil to Lymphocyte Ratio With Periprocedural Myocardial Damage in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Bressi E, Mangiacapra F, Ricottini E, Cavallari I, Colaiori I, Di Gioia G, Creta A, Di Sciascio G.
    Am J Cardiol; 2016 Oct 01; 118(7):980-4. PubMed ID: 27515894
    [Abstract] [Full Text] [Related]

  • 32. Comparison of Long-Term Mortality in Patients With Single Coronary Narrowing and Diabetes Mellitus to That of Patients With Multivessel Coronary Narrowing Without Diabetes Mellitus.
    Omair M, Koshy AN, Dinh DT, Brennan AL, Reid CM, Ajani AE, Duffy SJ, Farouque O, Yudi MB, Clark DJ.
    Am J Cardiol; 2021 Mar 01; 142():1-4. PubMed ID: 33285090
    [Abstract] [Full Text] [Related]

  • 33. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
    Zhong Z, Hou J, Zhang Q, Zhong W, Li B, Li C, Liu Z, Yang M, Zhao P.
    Lipids Health Dis; 2019 Feb 02; 18(1):40. PubMed ID: 30711009
    [Abstract] [Full Text] [Related]

  • 34. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
    Li XL, Guo YL, Zhu CG, Xu RX, Qing P, Wu NQ, Jiang LX, Xu B, Gao RL, Li JJ.
    J Am Heart Assoc; 2015 Jan 08; 4(1):e001412. PubMed ID: 25572484
    [Abstract] [Full Text] [Related]

  • 35. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F, Barbato E, Patti G, Gatto L, Vizzi V, Ricottini E, D'Ambrosio A, Wijns W, Di Sciascio G.
    JACC Cardiovasc Interv; 2010 Mar 08; 3(3):318-23. PubMed ID: 20298992
    [Abstract] [Full Text] [Related]

  • 36. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.
    Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S.
    J Am Coll Cardiol; 2016 May 17; 67(19):2224-2234. PubMed ID: 27079334
    [Abstract] [Full Text] [Related]

  • 37. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A, McGuire DK, de Lemos JA, Das SR, Berry JD, Brilakis ES, Banerjee S, Marso SP, Barsness GW, Simon DN, Roe M, Goyal A, Kosiborod M, Amsterdam EA, Kumbhani DJ.
    Circ Cardiovasc Qual Outcomes; 2016 May 17; 9(3):197-205. PubMed ID: 27166210
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial).
    De Luca G, Iorio S, Venegoni L, Marino P.
    Am J Cardiol; 2012 Jan 15; 109(2):202-7. PubMed ID: 22000773
    [Abstract] [Full Text] [Related]

  • 39. Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty.
    Verdoia M, Secco GG, Cassetti E, Schaffer A, Barbieri L, Perrone-Filardi P, Marino P, Suryapranata H, Sinigaglia F, De Luca G.
    Blood Coagul Fibrinolysis; 2014 Mar 15; 25(2):107-13. PubMed ID: 24480844
    [Abstract] [Full Text] [Related]

  • 40. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ, EVENT Registry Investigators.
    JACC Cardiovasc Interv; 2009 Nov 15; 2(11):1074-82. PubMed ID: 19926047
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.